How the Newest Drugs Will Change Glaucoma Therapy

0.25 CME
15 MINS
$0 FEE
SAVE
Newest Drugs

Overview

Provider Statement

This continuing medical education activity is provided by Vindico Medical Education.


Support Statement

This activity is supported by educational grants from Aerie Pharmaceuticals, Inc.; Allergan, Inc.; Bausch + Lomb; and Carl Zeiss Meditec, Inc.


Activity Description

This educational activity will discuss the efficacy of newly approved medications to treat glaucoma.


Target Audience

The intended audience for the activity is ophthalmologists and other health care professionals involved in the management of patients with glaucoma.


Learning Objective(s)

Upon successful completion of this activity, participants should be better able to analyze new medical advances for the treatment and management of glaucoma.


Chief Medical Editor

John R. Samples, MD
Clinical Professor
Elson S. Floyd College of Medicine
Washington State University
Spokane, WA
Director
Western Glaucoma Foundation
Olympia, WA


Faculty

Robert J. Noecker, MD, MBA
Director of Glaucoma
Ophthalmic Consultants of Connecticut
Assistant Clinical Professor of Ophthalmology
Yale University School of Medicine
Clinical Professor
Frank Netter School of Medicine
Quinnipiac University
Fairfield, CT


Reviewer

Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP


Accreditation

Vindico Medical Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.


Credit Designation

Vindico Medical Education designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This enduring material is approved for 1 year from the date of original release, April 21, 2020, through April 20, 2021.


How to Participate in This Activity and Obtain CME Credit

To participate in this CME activity, you must read the objective, answer the pretest question, view the content, and complete the posttest and evaluation. Provide only one (1) correct answer for the question. A satisfactory score is defined as answering the posttest question correctly. Upon receipt of the completed materials, if a satisfactory score on the posttest is achieved, Vindico Medical Education will issue an AMA PRA Category 1 Credit(s)™ Certificate.


Disclosures

In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support, all accredited providers are required to mitigate and disclose to the activity audience the relevant financial relationships of the planners, teachers, and authors involved in the development of accredited content. An individual has a relevant financial relationship if he or she has a financial relationship in any amount occurring in the past 12 months with a commercial interest whose products or services are discussed in the accredited activity content over which the individual has control. Relationship information appears below.

Chief Medical Editor and Faculty member report the following relationship(s)

Robert J. Noecker, MD, MBA
Consulting Fee: Aerie, Alcon, Allergan, Bausch + Lomb, Beaver-Visitec, Ethis Communications, Glaukos, IOP Inc, ISP Surgical, Novartis, Ocular Therapeutix
Speakers Bureau: Aerie, Alcon, Allergan, Bausch + Lomb, Beaver-Visitec, Ethis Communications, Glaukos, IOP Inc, ISP Surgical, Novartis, Ocular Therapeutix, Sight Sciences
Ownership Interest: ISP Surgical, Ocular Therapeutix, Sight Sciences

John R. Samples, MD
Royalty: Kugler, Springer
Intellectual Property/Patent: ALeyeGN
Consulting Fee: ALeyeGN, Allergan
Speakers Bureau: Aerie, Novartis

Reviewer reports the following relationship(s)

Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP
No relevant financial relationships to disclose.

Vindico Medical Education staff report the following relationship(s)

No relevant financial relationships to disclose.

Signed disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance.


Unlabeled and Investigational Usage

The audience is advised that this continuing medical education activity may contain references to unlabeled uses of US Food and Drug Administration (FDA)-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non–FDA-approved or investigational use of products/devices.


Copyright Statement

Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. Copyright © 2020 Vindico Medical Education. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any of Vindico Medical Education continuing medical education activities does not necessarily reflect the views and opinions of Vindico Medical Education. Neither Vindico Medical Education nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the US Food and Drug Administration. All readers and continuing education participants should verify all information before treating patients or utilizing any product.


CME Questions?

Contact us at cme@vindicoCME.com